UK Spy Chief Warns of Growing Threats From Russia and China Geopolitical Risks Loom for Global Markets Elon Musks OpenAI Attack Viewed as Competitive Strategy to Boost xAI Oppenheimer Initiates Knife River Coverage with Outperform Rating Highlighting Growth Potential Disneys Star Wars The Mandalorian and Grogu Opens with Lowest Thursday Previews in Franchise History Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Peaks AI Stocks in Focus Asias Currencies Under Pressure as Oil Prices Surge and US Dollar Strengthens Amid Iran Tensions IMPP Q1 2026 Earnings EPS Surges 64 Above Estimates Stock Declines on Lack of Revenue Disclosure CHMG Q1 2026 Earnings EPS Surpasses Estimates by Over 15 Amid Steady Performance OneSpan Q1 2026 Earnings EPS Beat Drives 234 Stock Gain Amid Solid Execution Hexcel Corporation HXL Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction AMPG Q1 2026 Earnings EPS Misses Estimates as Challenges Persist VERX Q1 2026 Earnings Modest EPS Beat Amid Strong Operational Execution Johnson Johnson JNJ Holds Steady Above 230 as Defensive Bid Lifts Shares Morgan Stanley Emerging Markets Debt Fund Inc MSD Holds Steady Near Resistance Amid Modest Uptick Ciena Corporation CIEN Edges Lower Amid Mixed Market Sentiment Key Levels in Focus Cellyan Biotechnology HKPD Holds Steady Near Support After Marginal Gains Globus Medical GMED Declines 37 as Selling Pressure Intensifies Testing Key Support Levels GitHubs Reliability Woes Challenge Microsofts AI Coding Ambitions Caleres CAL Q1 2026 Earnings EPS Beat Helps Narrow Loss Stock Gains 38 BingEx FLX Shares Edge Higher Testing Resistance Zone China Prepares Humanoid Robots for Employment as Part of Industrial Strategy Microbot Medical Inc MBOT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction IONQ Q1 2026 Earnings EPS Beat Drives DoubleDigit Stock Surge Despite Revenue Disconnect SEBI Proposes Overhaul of IPO Price Discovery Mechanism Amid Distortion Concerns Turtle Beach TBCH Q1 2026 Earnings EPS Misses Estimates Sharply as Stock Rises Despite Headwinds Pharming Group Q1 2026 Earnings Missed EPS Estimates Amid Operational Challenges MDRR Q2 2021 Earnings EPS Surprises Positive but Stock Unchanged